Millions of women worldwide are affected by breast cancer, a prevalent form of cancer. For approximately 8 out of 10 cases, invasive ductal carcinoma (IDC) is the most prevalent form of breast cancer. IDC is characterized by cancer cells that have spread beyond the milk ducts into the surrounding breast tissue.
While surgery, chemotherapy, and radiation therapy are commonly used to treat IDC, there is growing interest in alternative treatment options such as cryoablation provided by the ICE3
Read More
U.S. Digital Therapeutics Market to Reach $21.46B by 2030
What You Should Know:
The U.S. digital therapeutics market size is estimated to reach $21.46B by 2030, expanding at a CAGR of 33.8% from 2023 to 2030, according to a new reports by Coherent Market Insights, Inc. Digital therapeutics solutions help improve medication adherence with personalized incentives to encourage long-term behavior change in patients and people with chronic conditions. The report reveals government initiatives to digitalize healthcare is one of the key trends
Read More
Emory Healthcare and DispatchHealth Partner to Offer In-Home Care to Patients in Metro-Atlanta
What You Should Know:
Emory Healthcare and DispatchHealth collaborate to offer patients a new option to receive convenient and safe follow-up and/or high acuity medical care in the comfort of their own homes. The collaboration is designed to improve access to health care and reduce the total cost of care for patients throughout Atlanta, Georgia and surrounding communities. Additionally, in collaboration with Emory Healthcare, DispatchHealth will supplement the health system's
Read More
Report: Inaccurate Drug Discount Requests Reach Nearly $1B
What You Should Know:
Kalderos, a data infrastructure and analytics company, identified nearly $1B in inaccurate drug discount requests from 2016-Q1 2023 on its drug discount management platform.The report, titled "Mission Critical: Bringing drug discount stakeholders together so patients win," outlines Kalderos' vision for a new paradigm of cooperation among drug discount program stakeholders in which everyone benefits — particularly patients.
Rising Costs of Inaccurate Drug
Read More
M&A: Apixio and ClaimLogiq Merge to Minimize Reimbursement Inaccuracies
What You Should Know:
Apixio announced it has completed its merger with ClaimLogiq, a healthcare technology business that delivers savings for health plans by reducing claim errors prior to payment. Together, the combined entity will be branded as Apixio.Together, the combination of Apixio and ClaimLogiq’s critical infrastructure, artificial intelligence, and proprietary healthcare data will accelerate the shift toward outcomes-based reimbursement models by reducing costs, minimizing
Read More
Claroty & Siemens Healthineers Launches End-to-End Cybersecurity Solution
What You Should Know:
Medigate by Claroty announced its strategic partnership with medical technology company, Siemens Healthineers to protect healthcare enterprises from malicious cyberattacks. Through a combination of software, managed services, and medical device security data sharing, the solution will increase reliability for patients by boosting risk management and operational efficiency. Additionally, the two companies will share medical device product security
Read More
Simple HealthKit Launches At-Home Testing Kits on Walmart.com
What You Should Know:
Simple HealthKit, which provides the first human-centric, complete diagnostics platform with access to follow-up care for respiratory health, sexual health and chronic conditions partners with Walmart to make Simple HealthKit’s at-home HbA1c (Diabetes), Respiratory Wellness and Sexual Wellness Tests available at Walmart.com*.Simple HealthKit’s HbA1c (Diabetes) Tests identify key markers for Type 2 diabetes. Its Respiratory Wellness Tests identify Influenza A,
Read More
Range Biotechnologies Raises $5.2M to Advance Proteomics for Precision Health
What You Should Know:
Range Biotechnologies (Range Bio) announced $5.2M in seed funding, led by TechBio-focused ARTIS Ventures with participation from Pear VC, Page One Ventures, Civilization Ventures, Pillar, Four Cities Capital, Hawktail, and others. Proteomics, the study of proteins in the body, has the potential to improve human health in several ways. For example, proteomic studies can help identify which proteins correlate with a certain disease or drug response.
Read More
FemTech: Pomelo Care Secures $33M for Value-Based Virtual Maternity Care Platform
What You Should Know:
Pomelo Care, an NYC-based value-based virtual maternity care platform that improves maternal and newborn health outcomes, announced $33M in Seed and Series A funding led by Andreessen Horowitz. The latest round brings its total capital raised to date to $33M. The company supports its patients from preconception through an infant’s first year with personalized and proactive 24/7 care from a dedicated, multispecialty team.
Pregnancy & newborn care,
Read More
Amazon HealthLake Adds 3 New FHIR API Capabilities to Offerings
What You Should Know:
AWS announced the addition of three new capabilities to Amazon HealthLake’s managed FHIR API offerings. The launch of these three new capabilities benefits EHR system providers, ISVs, SIs, and IT teams working with healthcare organizations, by allowing them to simply leverage managed FHIR APIs to build interoperability applications or systems that conform to ONC and CMS patient access rules, reducing the burden of building and managing the underlying FHIR APIs
Read More
